Cefepime–Taniborbactam in Complicated Urinary Tract Infection
New England Journal of Medicine · 2024
DOI: 10.1056/nejmc2403590 ↗Kurz gefasst
Leserbrief in der Zeitschrift New England Journal of Medicine, 2024. Verfasst von Abi Manesh und 2 weiteren Autor:innen. Beteiligte Einrichtung: Christian Medical College, Vellore, India abimanesh@cmcvellore.ac.in. Hauptthemen laut MEDLINE: Anti-Bacterial Agents, Cefepime, Urinary Tract Infections. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 14 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Christian Medical College, Vellore, India abimanesh@cmcvellore.ac.in.
- National University of Singapore, Singapore, Singapore.
Zitieren
APA
Manesh, A., Varghese, G. M., & Paterson, D. L. (2024). Cefepime–Taniborbactam in Complicated Urinary Tract Infection. New England Journal of Medicine. https://doi.org/10.1056/nejmc2403590
Vancouver
Manesh A, Varghese GM, Paterson DL. Cefepime–Taniborbactam in Complicated Urinary Tract Infection. New England Journal of Medicine. 2024. doi:10.1056/nejmc2403590
BibTeX
@article{Manesh2024,
author = {Manesh, Abi and Varghese, George M and Paterson, David L},
title = {Cefepime–Taniborbactam in Complicated Urinary Tract Infection},
journal = {New England Journal of Medicine},
year = {2024},
doi = {10.1056/nejmc2403590}
}
EUVIMED